Tenvir-AF Tablets

Tenvir-AF, formulated under strict regulatory standards by Cipla, is a advanced prescription antiviral medication containing $25\text{ mg}$ of Tenofovir Alafenamide (TAF). Functioning as a high-potency Nucleotide Reverse Transcriptase Inhibitor (NRTI), it is clinically indicated for managing chronic Hepatitis B Virus (HBV) infection in adults and, as part of combination antiretroviral therapy, for treating HIV-1 infection. By selectively converting into its active form inside targeted cells, Tenvir-AF efficiently suppresses viral replication while maintaining significantly lower plasma concentrations than traditional formulations. Supplied in a 30-tablet bottle, it provides healthcare professionals with an optimized cornerstone option for effective viral suppression and safe long-term disease management.